You have 9 free searches left this month | for more free features.

Condition

Myelodysplastic Syndrome (2)

Delayed Graft Function (1)

Overall Status

Completed (3)

Sign in for free

Phase

phase 1/phase 2 (2)

phase 2 (1)

Sponsor

Opsona Therapeutics Ltd. (3)

Collaborator

H. Lee Moffitt Cancer Center and Research Institute (2)

M.D. Anderson Cancer Center (2)

Montefiore Medical Center (2)

New York Presbyterian Hospital (2)

Intervention

opn-305 (3)

placebo (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

opn-305

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Myelodysplastic Syndrome Trial in Houston (OPN-305)

Completed

Myelodysplastic Syndrome

OPN-305

Houston, Texas

Research Site

Jan 24, 2019

Myelodysplastic Syndrome Trial in United States (OPN-305)

Completed

Myelodysplastic Syndrome

OPN-305

Tampa, Florida
+3 more

Jan 24, 2019

Delayed Graft Function Trial in Worldwide (OPN-305, Placebo)

Completed

Delayed Graft Function

OPN-305
Placebo

Los Angeles, California
+49 more

Feb 15, 2017